WallStreetZenWallStreetZen

NASDAQ: KRON
Kronos Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KRON

Based on 1 analyst offering 12 month price targets for Kronos Bio Inc.
Min Forecast
$2.25+128.43%
Avg Forecast
$2.25+128.43%
Max Forecast
$2.25+128.43%

Should I buy or sell KRON stock?

Based on 1 analyst offering ratings for Kronos Bio Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KRON stock forecasts and price targets.

KRON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-19

1 of 1

Forecast return on equity

Is KRON forecast to generate an efficient return?
Company
N/A
Industry
-388.9%
Market
58.96%

Forecast return on assets

Is KRON forecast to generate an efficient return on assets?
Company
N/A
Industry
27.36%

KRON earnings per share forecast

What is KRON's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.33
Avg 2 year Forecast
-$1.36

KRON revenue forecast

What is KRON's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$8.6M+2.48%
Avg 2 year Forecast
$4.5M-46.5%
KRON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KRON revenue growth forecast

How is KRON forecast to perform vs Biotechnology companies and vs the US market?
Company
-64.38%
Industry
34.96%
Market
9.31%
KRON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KRON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KRON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRON$0.99$2.25+128.43%Buy
CLGN$5.12$12.50+144.14%Strong Buy
ALRN$2.80$19.00+578.57%Strong Buy
BLUE$0.53$3.61+582.99%Buy
CSBR$4.25N/AN/A
View Top Biotech Stocks

Kronos Bio Stock Forecast FAQ

Is Kronos Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KRON) stock is to Buy KRON stock.

Out of 1 analyst, 0 (0%) are recommending KRON as a Strong Buy, 1 (100%) are recommending KRON as a Buy, 0 (0%) are recommending KRON as a Hold, 0 (0%) are recommending KRON as a Sell, and 0 (0%) are recommending KRON as a Strong Sell.

If you're new to stock investing, here's how to buy Kronos Bio stock.

What is KRON's earnings growth forecast for 2024-2025?

(NASDAQ: KRON) Kronos Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Kronos Bio's earnings in 2024 is -$102,852,000.On average, 3 Wall Street analysts forecast KRON's earnings for 2024 to be -$79,992,859, with the lowest KRON earnings forecast at -$87,427,185, and the highest KRON earnings forecast at -$70,544,694.

In 2025, KRON is forecast to generate -$81,801,697 in earnings, with the lowest earnings forecast at -$105,515,568 and the highest earnings forecast at -$63,912,287.

What is KRON's revenue growth forecast for 2024-2025?

(NASDAQ: KRON) Kronos Bio's forecast annual revenue growth rate of -64.38% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Kronos Bio's revenue in 2024 is $8,411,000.On average, 2 Wall Street analysts forecast KRON's revenue for 2024 to be $519,739,538, with the lowest KRON revenue forecast at $435,327,084, and the highest KRON revenue forecast at $604,151,992.

In 2025, KRON is forecast to generate $271,325,745 in revenue, with the lowest revenue forecast at $241,178,440 and the highest revenue forecast at $301,473,050.

What is KRON's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KRON) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 27.36%.

What is KRON's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KRON price target, the average KRON price target is $2.25, with the highest KRON stock price forecast at $2.25 and the lowest KRON stock price forecast at $2.25.

The Wall Street analyst predicted that Kronos Bio's share price could reach $2.25 by Aug 19, 2025. The average Kronos Bio stock price prediction forecasts a potential upside of 128.43% from the current KRON share price of $0.99.

What is KRON's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: KRON) Kronos Bio's current Earnings Per Share (EPS) is -$1.74. On average, analysts forecast that KRON's EPS will be -$1.33 for 2024, with the lowest EPS forecast at -$1.45, and the highest EPS forecast at -$1.17. In 2025, KRON's EPS is forecast to hit -$1.36 (min: -$1.75, max: -$1.06).

What is KRON's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KRON) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.